Literature DB >> 10023422

Other medical management of uterine fibroids.

T Eldar-Geva1, D L Healy.   

Abstract

Several medicines are emerging with the potential to treat symptomatic uterine fibroids. Anti-progesterone compounds seem particularly promising. These drugs have been widely used for nearly 20 years and are known to be safe; medical politics have prevented their proper investigation for uterine fibroids. In particular, the value of mifepristone, 50 mg per day for 3 months, seems particularly promising. Further investigation is clearly warranted for this medicine. Several anti-oestrogen compounds have recently become available and may also be useful for the medical treatment of symptomatic uterine fibroids. This includes the possibility of the use of selective oestrogen receptor modulators as well as the prospect of the use of pure anti-oestrogens. On a longer time frame, inhibitors of angiogenesis may be useful. These medicines would act upon the blood supply to uterine fibroids. Physicians also have an obligation to investigate scientifically any promising naturopathic treatment that appears to have possible activity for symptomatic fibroids.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10023422     DOI: 10.1016/s0950-3552(98)80064-3

Source DB:  PubMed          Journal:  Baillieres Clin Obstet Gynaecol        ISSN: 0950-3552


  3 in total

Review 1.  Role of vitamin D in uterine fibroid biology.

Authors:  Soumia Brakta; Justin S Diamond; Ayman Al-Hendy; Michael P Diamond; Sunil K Halder
Journal:  Fertil Steril       Date:  2015-06-13       Impact factor: 7.329

2.  Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas.

Authors:  O Reich; S Regauer; W Urdl; M Lahousen; R Winter
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

3.  The Effect of Vitamin D Deficiency on Overgrowth of Uterine Fibroids: A Blinded Randomized Clinical Trial.

Authors:  Fatemeh Davari Tanha; Elham Feizabad; Maryam Vasheghani Farahani; Hoora Amuzegar; Behnaz Moradi; Saghar Samimi Sadeh
Journal:  Int J Fertil Steril       Date:  2021-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.